Pain, Chronic
0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
City TherapeuticsMA - Cambridge
1 programPulse Radiofrequency to the suprascapular nerveN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
City TherapeuticsPulse Radiofrequency to the suprascapular nerve
Nalu MedicalNalu Neurostimulation System
PfizerPath Pain
Clinical Trials (3)
Total enrollment: 157 patients across 3 trials
Pulsed Radiofrequency to the Suprascapular Nerve
Start: Jun 2023Est. completion: Jan 2024
N/ACompleted
Spinal Cord Stimulation in the Treatment of Chronic, Intractable Pain Using the Nalu™ Neurostimulation System
Start: Jul 2020Est. completion: Sep 2022
N/ACompleted
A Personalized Self-Management Program for Older Adults With Chronic Pain and Negative Emotions
Start: Aug 2017Est. completion: Jul 2019157 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space